Publication:

Individual assessment of pharmacological risk in patients receiving home care services in the Cartagena city

Abstract in english

Currently there are scales or strategies that evaluate some risks associated with the use of medications in specific population groups, but they do not consider some important variables that are found during pharmaceutical care. The Individual Pharmacological Risk Evaluation Scale (EEIRF) that is used during the application of the DETI Method of Pharmaceutical care is an efficient tool to know the Individual Pharmacological Risk of a patient, facilitating its comprehensive approach and the generation of strategies for the team of care and the patient. METHOD: A descriptive, longitudinal, prospective study was carried out that included patients from the Home Care program. For the Individual Evaluation of the Pharmacological Risk of the patients, the DETI method of Pharmaceutical Care and Pharmacotherapeutic Follow-up and its EEIRF were applied. RESULTS: The clinical and environmental conditions were identified that allowed defining the probability that a patient would present Adverse situations or Health Problems associated with their use of the Medications they received and it was found that 22% of the patients were exposed to a Very High Pharmacological Risk. High, 27% at High risk, 46% at Moderate risk and 5% at Low risk. CONCLUSION: In the study population, the pharmacological risk to which a patient is exposed according to the EEIRF is evident by the variables measured and according to its quantification, 95% of them require Pharmaceutical attention and Pharmacotherapeutic Follow-up Every 2, 3 or 6 Months or sooner depending on condition clinic due to its VERY HIGH, HIGH and MODERATE PROBABILITY of presenting Adverse situations or Health Problems associated with the use of the Medications you receive.